Amarin Corporation (AMRN, quote) is an Irish, late-stage biopharmaceutical company that is starting to attract the attention of institutional investors.
Biotechnology stocks around the globe rose yesterday when Bristol Myers Squibb (BMY, quote) offered to buy Amylin Pharmaceuticals (AMLN, quote) at a huge premium.
